These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Commentary on "Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle." Mertens LS, Fioole-Bruining A, Vegt E, Vogel WV, van Rhijn BW, Horenblas S, Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam Hospital, Amsterdam, The Netherlands.: BJU Int 2013; 112(6):72934. doi:10.1111/bju.12109. [Epub 2013 Jun 24]. See WA Urol Oncol; 2014 Nov; 32(8):1350. PubMed ID: 25488385 [TBL] [Abstract][Full Text] [Related]
9. Interesting image. Correlative imaging with FDG PET-CT and MRI of an unusual recurrence of urothelial cancer in an ileal conduit. Purandare NC; Dua S; Shah S; Gupta K; Sharma AR; Rangarajan V Clin Nucl Med; 2010 Jan; 35(1):42-3. PubMed ID: 20026976 [No Abstract] [Full Text] [Related]
10. Extraperitoneal urinary bladder perforation detected by FDG PET/CT. Wosnitzer B; Mirtcheva R J Radiol Case Rep; 2011; 5(4):32-40. PubMed ID: 22470789 [TBL] [Abstract][Full Text] [Related]
11. Reduction of bladder activity on FDG PET/CT scan in patients with urinary bladder carcinoma. A prospective study with a patient-friendly protocol. Tsai SC; Ou YC; Cheng CL; Li JR; Lin YC; Ho HC; Chiu KY; Su CK; Lin WY Nuklearmedizin; 2015; 54(1):36-42. PubMed ID: 25345433 [TBL] [Abstract][Full Text] [Related]
12. A rare case of large cell neuroendocrine carcinoma of the urinary bladder evaluated by ¹⁸F-FDG-PET/CT. Treglia G; Paone G; Flores B; Venzi G; Ceriani L; Giovanella L Rev Esp Med Nucl Imagen Mol; 2014; 33(5):312-3. PubMed ID: 24440201 [No Abstract] [Full Text] [Related]
14. Proposal of a new acquisition protocol for bladder cancer visualization with 18F-FDG PET/CT. Chondrogiannis S; Marzola MC; Colletti PM; Rubello D Clin Nucl Med; 2015 Jan; 40(1):e78-80. PubMed ID: 24566416 [TBL] [Abstract][Full Text] [Related]
15. Feasible method to successfully uncover a urothelial carcinoma in the urinary bladder on the FDG PET/CT scan masked by physiological urine radioactivity. Shen YY; Kao CH; Yeh LH; Juang GD; Liang JA; Hsieh TC Clin Nucl Med; 2010 Jun; 35(6):464-6. PubMed ID: 20479605 [No Abstract] [Full Text] [Related]
16. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer. Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965 [TBL] [Abstract][Full Text] [Related]
17. [(18)F]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy. Kollberg P; Almquist H; Bläckberg M; Cronberg C; Garpered S; Gudjonsson S; Kleist J; Lyttkens K; Patschan O; Liedberg F Scand J Urol; 2015; 49(4):296-301. PubMed ID: 25623843 [TBL] [Abstract][Full Text] [Related]
18. Delayed imaging of the pelvis with diluted and filled bladder: a simple and efficient method in FDG PET/CT imaging of bladder carcinoma. Halac M; Aliyev A; Yılmaz S; Ozhan M; Kaya R; Sağer S; Ergül N Clin Nucl Med; 2012 Aug; 37(8):778-80. PubMed ID: 22785509 [TBL] [Abstract][Full Text] [Related]
19. Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study. Zattoni F; Incerti E; Colicchia M; Castellucci P; Panareo S; Picchio M; Fallanca F; Briganti A; Moschini M; Gallina A; Karnes JR; Lowe V; Fanti S; Schiavina R; Rambaldi I; Ficarra V; Evangelista L Abdom Radiol (NY); 2018 Sep; 43(9):2391-2399. PubMed ID: 29302738 [TBL] [Abstract][Full Text] [Related]